Skip to main content

06-12-2018 | Breast cancer | Video

Study TAM01: Low-dose tamoxifen prevents breast intraepithelial neoplasia recurrence

Andrea DeCensi outlines his study findings demonstrating that low-dose tamoxifen 5 mg/day significantly lowers the recurrence of intraepithelial neoplasia versus placebo without increasing endometrial cancer and deep vein thrombosis (3:32).

Funding for these videos was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland

See the research in context now

with trial summaries, expert opinion and congress coverage

Image Credits